• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白蛋白尿对糖尿病患者各种死因的影响:一项全国范围内基于人群的研究。

Impact of albuminuria on the various causes of death in diabetic patients: a nationwide population-based study.

机构信息

Department of Internal Medicine, Chung-Ang University Gwang-Myeong Hospital, Gwangmyeong-si, Korea.

Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.

出版信息

Sci Rep. 2023 Jan 6;13(1):295. doi: 10.1038/s41598-022-23352-0.

DOI:10.1038/s41598-022-23352-0
PMID:36609387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9822964/
Abstract

Diabetes mellitus (DM) is a well-known risk factor for mortality, and the risk is exacerbated by coexisting diabetic kidney disease (DKD). We aimed to explore the impact of DM on each cause of mortality according to kidney function and the presence of albuminuria. Data on subjects with DM were extracted from the Nationwide Health Insurance Database of South Korea between 2009 and 2012. Subjects were divided by eGFR and albuminuria into five groups. To evaluate the risk of diabetes, we used the Cox proportional hazards model. A total of 2,614,662 patients were enrolled in this study. Most causes of death showed a higher incidence in an advanced stage of DKD. In addition to all-cause mortality and cardiovascular death, the risk of death from neoplasms and diseases of the endocrine, respiratory, and digestive systems is increased by albuminuria. The synergistic effect of a reduced eGFR and the presence of albuminuria was prominent in death from circulatory diseases, and endocrine and metabolic diseases. The risk for mortality was different according to the stage of DKD. Even in patients with a favorable eGFR, the presence of albuminuria significantly increased the risk for mortality, especially that due to cardiovascular causes.

摘要

糖尿病(DM)是众所周知的死亡风险因素,而并存的糖尿病肾病(DKD)会使风险加剧。我们旨在根据肾功能和白蛋白尿的存在,探讨 DM 对每种死亡原因的影响。2009 年至 2012 年,从韩国国家健康保险数据库中提取了有 DM 病史的受试者的数据。根据 eGFR 和白蛋白尿将受试者分为五组。为了评估糖尿病的风险,我们使用了 Cox 比例风险模型。共有 2614662 名患者纳入本研究。大多数死因在 DKD 的晚期表现出更高的发生率。除了全因死亡率和心血管死亡率外,白蛋白尿还增加了肿瘤和内分泌、呼吸和消化系统疾病的死亡风险。eGFR 降低和白蛋白尿的协同作用在循环系统疾病和内分泌代谢疾病的死亡中表现明显。死亡率因 DKD 分期而异。即使在 eGFR 良好的患者中,白蛋白尿的存在也显著增加了死亡率的风险,尤其是心血管原因导致的死亡率。

相似文献

1
Impact of albuminuria on the various causes of death in diabetic patients: a nationwide population-based study.白蛋白尿对糖尿病患者各种死因的影响:一项全国范围内基于人群的研究。
Sci Rep. 2023 Jan 6;13(1):295. doi: 10.1038/s41598-022-23352-0.
2
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.非白蛋白尿性糖尿病肾病与 2 型糖尿病全因死亡率及心血管和肾脏结局的关系:来自香港糖尿病生物库的研究结果。
Am J Kidney Dis. 2022 Aug;80(2):196-206.e1. doi: 10.1053/j.ajkd.2021.11.011. Epub 2022 Jan 6.
3
Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.根据蛋白尿和估计肾小球滤过率评估糖尿病患者心血管疾病、死亡及肾脏进展的风险
Diabetes Metab. 2023 Mar;49(2):101420. doi: 10.1016/j.diabet.2023.101420. Epub 2023 Jan 12.
4
The prognosis of subjects showing a reduced estimated glomerular filtration rate without albuminuria in Japanese patients with type 2 diabetes: a cohort study for diabetic kidney disease.日本 2 型糖尿病患者中无蛋白尿但肾小球滤过率估算值降低患者的预后:一项糖尿病肾脏疾病队列研究。
Clin Exp Nephrol. 2020 Nov;24(11):1033-1043. doi: 10.1007/s10157-020-01935-3. Epub 2020 Jul 30.
5
2023 Diabetic Kidney Disease Fact Sheet in Korea.2023 年韩国糖尿病肾病情况说明书。
Diabetes Metab J. 2024 May;48(3):463-472. doi: 10.4093/dmj.2023.0310. Epub 2024 Mar 19.
6
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.非白蛋白尿性肾功能不全是 2 型糖尿病患者死亡的强有力预测因素:肾功能不全和心血管事件(RIACE)意大利多中心研究。
Diabetologia. 2018 Nov;61(11):2277-2289. doi: 10.1007/s00125-018-4691-2. Epub 2018 Jul 21.
7
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.定义慢性肾脏病对 2 型糖尿病患者全因死亡率的影响:肾功能不全和心血管事件(RIACE)意大利多中心研究。
Acta Diabetol. 2018 Jun;55(6):603-612. doi: 10.1007/s00592-018-1133-z. Epub 2018 Mar 24.
8
Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?糖尿病肾病:2型糖尿病患者中是否存在非白蛋白尿表型?
Nefrologia. 2016 Sep-Oct;36(5):503-509. doi: 10.1016/j.nefro.2016.03.025. Epub 2016 Jul 18.
9
The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).2 型糖尿病伴非白蛋白尿性糖尿病肾病患者的预后并非总是较差:共存大血管并发症的影响意义(JDDM 54)。
Diabetes Care. 2020 May;43(5):1102-1110. doi: 10.2337/dc19-2049. Epub 2020 Mar 6.
10
Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study.2 型糖尿病患者的糖尿病肾病:一项横断面研究。
BMC Nephrol. 2021 Jun 16;22(1):223. doi: 10.1186/s12882-021-02429-4.

引用本文的文献

1
Association between creatinine clearance and mortality in Chinese patients with osteoporotic fractures: a retrospective cohort study.中国骨质疏松性骨折患者肌酐清除率与死亡率的关联:一项回顾性队列研究。
Front Med (Lausanne). 2025 Aug 14;12:1550525. doi: 10.3389/fmed.2025.1550525. eCollection 2025.
2
Diabetic retinopathy and diabetic kidney disease, either isolated or associated, impact on the 10-year risk of cardiovascular disease: are we dealing with similar conditions?糖尿病视网膜病变和糖尿病肾病,无论是单独出现还是同时存在,都会影响心血管疾病的10年发病风险:我们面对的是相似的情况吗?
Arch Endocrinol Metab. 2025 May 9;69(2):e240258. doi: 10.20945/2359-4292-2024-0258.
3

本文引用的文献

1
Diabetic kidney disease treatment: new perspectives.糖尿病肾病治疗:新视角
Kidney Res Clin Pract. 2022 Sep;41(Suppl 2):S63-S73. doi: 10.23876/j.krcp.21.288. Epub 2022 Sep 30.
2
Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study.二甲双胍在糖尿病合并慢性肾脏病患者中的应用与心血管结局:一项全国性队列研究。
Kidney Res Clin Pract. 2021 Dec;40(4):660-672. doi: 10.23876/j.krcp.20.222. Epub 2021 Nov 29.
3
Proteinuria Is Associated with the Development of Crohn's Disease: A Nationwide Population-Based Study.
Renal effects and safety of tirzepatide in subjects with and without diabetes: A systematic review and meta-analysis.
替尔泊肽在糖尿病和非糖尿病受试者中的肾脏效应及安全性:一项系统评价和荟萃分析
World J Diabetes. 2025 Feb 15;16(2):101282. doi: 10.4239/wjd.v16.i2.101282.
4
Tirzepatide Prescribing Practices and Efficacy in Patients with Diabetes and Chronic Kidney Disease at a Large Tertiary Care Center in the United States.在美国一家大型三级医疗中心,替尔泊肽在糖尿病和慢性肾脏病患者中的处方实践及疗效
Diabetes Metab Syndr Obes. 2024 Oct 3;17:3621-3628. doi: 10.2147/DMSO.S473319. eCollection 2024.
5
Dose and Time Effects of Renin-Angiotensin Inhibitors on Patients With Advanced Stages 4 to 5 of Diabetic Kidney Disease.肾素-血管紧张素抑制剂对4至5期晚期糖尿病肾病患者的剂量和时间效应
J Endocr Soc. 2024 Jun 11;8(8):bvae119. doi: 10.1210/jendso/bvae119. eCollection 2024 Jul 1.
6
The Cardiac-Kidney-Liver (CKL) syndrome: the "real entity" of type 2 diabetes mellitus.心肾肝(CKL)综合征:2型糖尿病的“真实实体”。
Arch Med Sci. 2024 Jan 31;20(1):207-215. doi: 10.5114/aoms/183070. eCollection 2024.
7
Progress in Cardiac Magnetic Resonance Feature Tracking for Evaluating Myocardial Strain in Type-2 Diabetes Mellitus.心脏磁共振特征追踪技术评估 2 型糖尿病心肌应变的研究进展。
Curr Diabetes Rev. 2024;20(8):98-109. doi: 10.2174/0115733998277127231211063107.
蛋白尿与克罗恩病的发生相关:一项基于全国人口的研究。
J Clin Med. 2021 Feb 16;10(4):799. doi: 10.3390/jcm10040799.
4
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.肾脏高滤过与 2 型糖尿病患者全因死亡率增加独立相关:一项前瞻性队列研究。
BMJ Open Diabetes Res Care. 2020 Jul;8(1). doi: 10.1136/bmjdrc-2020-001481.
5
Long-term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome.患有代谢综合征的2型糖尿病患者发生恶性肿瘤性疾病的长期风险。
Diabetes Metab Syndr Obes. 2020 Apr 23;13:1317-1326. doi: 10.2147/DMSO.S243263. eCollection 2020.
6
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.2019 年全球及各区域糖尿病患病率估算值及 2030 年和 2045 年预测值:国际糖尿病联盟糖尿病地图集(第 9 版)的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
7
Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study.白蛋白尿、肺功能下降与新发慢性阻塞性肺疾病风险:美国国立卫生研究院心肺血液研究所队列研究
Am J Respir Crit Care Med. 2019 Feb 1;199(3):321-332. doi: 10.1164/rccm.201803-0402OC.
8
Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.阿尔茨海默病与2型糖尿病:对共同病理特征的批判性评估
Front Neurosci. 2018 Jun 8;12:383. doi: 10.3389/fnins.2018.00383. eCollection 2018.
9
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.心血管结局与 2 型糖尿病高心血管风险患者的尿白蛋白和肾脏疾病的关系:来自 SAVOR-TIMI 53 试验的观察。
JAMA Cardiol. 2018 Feb 1;3(2):155-163. doi: 10.1001/jamacardio.2017.4228.
10
Diabetic Kidney Disease: Challenges, Progress, and Possibilities.糖尿病肾病:挑战、进展与可能。
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045. doi: 10.2215/CJN.11491116. Epub 2017 May 18.